FDA warns of potential diabetes risk, cognitive adverse events with statins

Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology

View the original article here